Clinical Trial Update: A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how itraconazole and rifampin affect the pharmacokinetics of talazoparib in patients with advanced solid tumors; results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Itraconazole (Itraconazole)
• RIFAMPIN (RIFAMPIN)
• Talazoparib (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2019-03-29